163 related articles for article (PubMed ID: 35208821)
1. Distribution of
Sorrentino L; Silvestri V; Oliveto G; Scordio M; Frasca F; Fracella M; Bitossi C; D'Auria A; Santinelli L; Gabriele L; Pierangeli A; Mastroianni CM; d'Ettorre G; Antonelli G; Caruz A; Ottini L; Scagnolari C
Microorganisms; 2022 Feb; 10(2):. PubMed ID: 35208821
[TBL] [Abstract][Full Text] [Related]
2. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
Stättermayer AF; Strassl R; Maieron A; Rutter K; Stauber R; Strasser M; Beinhardt S; Datz C; Scherzer TM; Steindl-Munda P; Gschwantler M; Trauner M; Hofer H; Ferenci P
Aliment Pharmacol Ther; 2014 Jan; 39(1):104-11. PubMed ID: 24205831
[TBL] [Abstract][Full Text] [Related]
4. Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes.
Lang Kuhs KA; Kuniholm MH; Pfeiffer RM; Chen S; Desai S; Edlin BR; Peters MG; Plankey M; Sharp GB; Strickler HD; Villacres MC; Quinn TC; Gange SJ; Prokunina-Olsson L; Greenblatt RM; O'Brien TR
PLoS One; 2015; 10(10):e0138827. PubMed ID: 26431156
[TBL] [Abstract][Full Text] [Related]
5. A Novel Inactive Isoform with a Restored Reading Frame Is Expressed from the Human Interferon Lambda 4 TT Allele at rs368234815.
Bharatiya S; Agarwal A; Chinnaswamy S
J Interferon Cytokine Res; 2023 Sep; 43(9):370-378. PubMed ID: 36880961
[TBL] [Abstract][Full Text] [Related]
6. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.
Konishi H; Motomura T; Matsumoto Y; Harimoto N; Ikegami T; Yoshizumi T; Soejima Y; Shirabe K; Fukuhara T; Maehara Y
J Viral Hepat; 2014 Jun; 21(6):397-404. PubMed ID: 24750545
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
[TBL] [Abstract][Full Text] [Related]
8. The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients.
Rahimi P; Tarharoudi R; Rahimpour A; Mosayebi Amroabadi J; Ahmadi I; Anvari E; Siadat SD; Aghasadeghi M; Fateh A
Virol J; 2021 Nov; 18(1):221. PubMed ID: 34775984
[TBL] [Abstract][Full Text] [Related]
9. Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients.
Alves CF; Grott CS; Lunge VR; Béria JU; Tietzmann DC; Stein AT; Simon D
Genet Mol Biol; 2016; 39(3):374-9. PubMed ID: 27560987
[TBL] [Abstract][Full Text] [Related]
10. Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
Wiegand SB; Heidrich B; Susser S; Rogalska-Taranta M; Petersen J; Böker KH; Grigorian N; Link R; Naumann U; John C; Lueth S; Malfertheiner P; Manns MP; Wedemeyer H; Sarrazin C; Cornberg M
PLoS One; 2015; 10(12):e0145622. PubMed ID: 26699619
[TBL] [Abstract][Full Text] [Related]
11. Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C.
Nagaoki Y; Imamura M; Kawakami Y; Kan H; Fujino H; Fukuhara T; Kobayashi T; Ono A; Nakahara T; Naeshiro N; Urabe A; Yokoyama S; Miyaki D; Murakami E; Kawaoka T; Tsuge M; Hiramatsu A; Aikata H; Takahashi S; Hayes CN; Ochi H; Chayama K;
Hepatol Res; 2014 Dec; 44(14):E447-54. PubMed ID: 24690180
[TBL] [Abstract][Full Text] [Related]
12. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
[TBL] [Abstract][Full Text] [Related]
13. IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C.
Mori N; Imamura M; Kawakami Y; Nagaoki Y; Kawaoka T; Tsuge M; Hiramatsu A; Hayes CN; Aikata H; Miki D; Ochi H; Honda Y; Takaki S; Tsuji K; Chayama K;
Hepatol Res; 2017 Mar; 47(3):E5-E13. PubMed ID: 27027531
[TBL] [Abstract][Full Text] [Related]
14. The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.
Holmes JA; Congiu M; Bonanzinga S; Sandhu MK; Kia YH; Bell SJ; Nguyen T; Iser DM; Visvanathan K; Sievert W; Bowden DS; Desmond PV; Thompson AJ
Aliment Pharmacol Ther; 2015 Aug; 42(3):296-306. PubMed ID: 26032235
[TBL] [Abstract][Full Text] [Related]
15. Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
Amanzada A; Kopp W; Spengler U; Ramadori G; Mihm S
PLoS One; 2013; 8(12):e84026. PubMed ID: 24376784
[TBL] [Abstract][Full Text] [Related]
16. Its all about IFN-λ4: Protective role of IFNL4 polymorphism against COVID-19-related pneumonia in females.
Matic S; Milovanovic D; Mijailovic Z; Djurdjevic P; Sazdanovic P; Stefanovic S; Todorovic D; Popovic S; Vitosevic K; Vukicevic V; Vukic M; Vukovic N; Milivojevic N; Zivanovic M; Jakovljevic V; Filipovic N; Djordjevic N; Baskic D
J Med Virol; 2023 Oct; 95(10):e29152. PubMed ID: 37812032
[TBL] [Abstract][Full Text] [Related]
17. Single Nucleotide Polymorphism of Interferon Lambda-4 Gene is not Associated with Treatment Response to Pegylated Interferon in Thai Patients with Chronic Hepatitis B.
Limothai U; Wasitthankasem R; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(13):5515-9. PubMed ID: 26225703
[TBL] [Abstract][Full Text] [Related]
18. Interferon lambda 4 genotype and pathway in alcoholic hepatitis.
Støy S; Terczynska-Dyla E; Veidal SS; Rigbolt K; Vilstrup H; Grønbaek H; Hartmann R; Sandahl TD
Scand J Gastroenterol; 2021 Mar; 56(3):304-311. PubMed ID: 33602032
[TBL] [Abstract][Full Text] [Related]
19.
Baker FS; Wang J; Florez-Vargas O; Brand NR; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Chagaluka G; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Prokunina-Olsson L; Mbulaiteye SM
J Interferon Cytokine Res; 2023 Sep; 43(9):394-402. PubMed ID: 37366802
[TBL] [Abstract][Full Text] [Related]
20. Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A.
Akamatsu S; Hayes CN; Ochi H; Uchida T; Kan H; Murakami E; Abe H; Tsuge M; Miki D; Akiyama R; Hiraga N; Imamura M; Aikata H; Kawaoka T; Kawakami Y; Chayama K
J Hepatol; 2015 Sep; 63(3):554-63. PubMed ID: 25849245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
